U.S. Markets closed

Celgene Corporation (CELG)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
127.65+0.07 (+0.05%)
At close: 4:00PM EDT
People also watch
GILDBIIBREGNAMGNVRTX
  • H
    Horowitz
    Horowitz

    SNOA (MC $23 M) (Cash $13 M) Shares Out: 4.3 M / 17 FDA approved products some of them are in early launch phase plus additional Product launches expected within 6 months / Profitable in 2018 = 1000%+ UPSIDE POTENTIAL..GLTA

    Sonoma Pharma (Nasdaq: SNOA)

    Market Cap: 22.1 Million
    Cash: $12.6 Million
    Price: $5.15

    Shares Out : 4.3 Million

    Presentation
    http://ir.sonomapharma.com/common/download/download.cfm?companyid=ocls&fileid=945547&filekey=F57B6874-6CD1-4205-A160-8E08BBB7A928&filename=SonomaPharma_Investor_presentation_13June2017.pdf

    Fact Sheet
    http://files.shareholder.com/downloads/OCLS/4977255852x0x231236/39d834a3-8462-40ee-8650-e0945b6facd5/Sonoma_Fact_Sheet.pdf

    Driving to commercial EBITDAS breakeven, without dilution

    Grow current product portfolio with all sales people

    •Alevicyn HydroGel, Dermal Spray & Spray Gel for atopic dermatitis & dermal procedures •Celacyn for scar treatment
    •Mondoxyne for severe acne –launched late 2015
    •Ceramax for skin repair in atopic dermatitis–launched in April 2016
    •SebuDerm for seborrhea dermatitis –launched in November 2016

    Launch 3 New Products –our product pipeline –one every other quarter

    •Launching Loyon–Fall 2017
    •Ceramax in foam and gel forms –Q4 2017 & Q1 2018

    Launch and Grow New and Current Products: During fiscal year 2017, we launched four new dermatology products, including SebuDerm™, Ceramax™, Lasercyn™ Gel and Lasercyn™ Dermal Spray, bringing us to a total of eight dermatology products for the treatment of atopic and seborrheic dermatitis, scar management, surgical procedures, severe acne and “state of the art” skin repair technology. We also obtained three new FDA clearances, now totaling 16 overall. Our strong intellectual property portfolio consists of 63 issued patents and 33 patent applications pending.

    We plan to launch our new FDA approved product Loyon® (a skin descaler currently marketed in Europe) in the upcoming months and have a strong product pipeline of several product line improvements, including a line extension of Ceramax™. All in all, we believe this could possibly be our best product line of new FDA approved dermatology and skincare products yet, and we believe our innovation plan will help lead us to profitability.

  • M
    Matt
    Matt
    there several posters who are either short w/stock, or owners of puts. probably wise to pay no attn to their comments. commenting with negativity typically means they think by making bad comments you might sell your stock, so that they can proffit!
  • a
    askdoctorjl
    askdoctorjl
    I'm somewhat new to Celgn but like the company and was wondering if someone would fill me in on why the sell off?
  • O
    Olivia
    Olivia
    CELG appears to suggest upside opportunity. This is so frustrating trying to find trade ideas. I've subscribed to some email newsletters which helps me with new stock ideas. awe-some*sto-cks is the one i like best.
  • J
    John
    John
    IBD post says CELG below its 50 day MA and "that's troubling". FIB retracement says next stop is 50% at $126.34. In just a mere 15 trading days since positive earnings CELG has plummeted $11.50 per share. There are obviously some issues the company needs to resolve or this stock could be back at $115 or lower by Labor Day. I want some of what the analysts are smoking.
  • a
    allan
    allan
    this is August everything you hear is b's Aug is bad for stock s but notoriously bad for bios
  • M
    Matt
    Matt
    celg remains the best bio-tech out there.....this a buying opportunity, BEEG TIME. naysaysers and shorters on wong track.... best to close short positions and go long,
    oh, did i mention i am a tad bullish, and long? yeppo. g.l. to longs.
  • s
    spam
    spam
    livin up to my name... check out AAXN buying opportunity here, Q over Q beat/guidance, do some DD and thank me later!
  • a
    allan
    allan
    Aug real bad for bios but celg is way undervalued
  • a
    allan
    allan
    celg with a pe of 16 looks good they will earn 7.30 dlrs per share this yr and over 8 something next yr its way undervalued
  • a
    allan
    allan
    it's August geez get a grip
  • a
    allan
    allan
    celg has pe around 16 and grows 19 percent a yr grossly undervalued
  • m
    martyboy17
    martyboy17
    I'm done, war imminent, trump alpha male, won't back down. Averages will fall 25%. I sold Celgene today and put it all in RTN.
  • D
    Darren
    Darren
    XBIO and BCDA looking good and about make a leap.
  • C
    Crankheart
    Crankheart
    Sold this at open. Back in low 120s
  • a
    allan
    allan
    Aug is typically poor for bios but celg is so damn cheap
  • m
    martyboy17
    martyboy17
    Pretty weak today, trending down. Hour left, enough volume we could see - 2.60 plus. Due for a breather, I only have 150 at 107.00, but I'd like to get 150 more in the low 120.00's. Truthfully, I don't think that's going to happen. I wish we'd get a 10% correction, there's a ton of cash waiting for an excuse to get in. This what would occur. Dow drops to 19,450 are, money chasing the "buying opportunity" all in, dollar cost ave abandoned, new money get in. Dow regains 22,000 in 5 weeks and then bolts to 25,650 by year end, supported by good jobs numbers, an overall improving economy, consumer confidence up, low inflation, but some rising rates, and the little fat price pos in north korea turned into a glass statue. I am done with the threats, are you? However, he may have an EMP planned for us. RIP everyone, it's over and it is a damn straight posibility. We all die in weeks or months. I don't think will do anything to him, unless we harden the grid now, three billion and two years, get the F on it congress!!!! Then we might have to take the stategic risk of losing a city here or elsewhere to the crazy fat boy, but then, we would lite that pos little creep to kingdom come. Hey fat boy, #$%$.
  • a
    allan
    allan
    celg way way undervalued
  • a
    allan
    allan
    celg keeps producing better numbers
  • C
    Cliff
    Cliff
    FDA approves leukemia treatment developed by Celgene and Agios